News
Pharmaceutical Technology on MSN6d
Novartis concludes Regulus Therapeutics acquisitionThe transaction was approved by both companies' boards and includes a significant premium over recent stock prices for ...
New research by Sumeda Nandadasa, Ph.D., reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...
New research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...
Basel: Novartis has announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. With the ...
One of the leading causes of kidney disease in non-diabetics is high blood pressure, also called hypertension. The kidneys ...
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?
Jim FessendenUMass Chan Medical SchoolNew research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome ...
AZoLifeSciences on MSN1d
Study Finds Protein Cleavage Essential for Healthy Cilia and Cell SignalingNew research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...
5don MSN
As Canada launches its new disability benefit payments in July, medical and disability experts are raising alarms over ...
India Today on MSN4d
Endocrinologist Dr. Ambrish Mithal on the happy side-effects of weight-loss drugsNew GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits. Dr. Ambrish Mithal, India's top endocrinologist, in an episode of Booked, highlights the impact of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback